What is Pacira BioSciences, Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Pacira BioSciences, Inc.'s reported free cash flow gives $78.48 per share. The share price was $36.50 on November 10, 2026, 53% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 6.0% | 10.0% | $47.53 | +30% |
| Base | 11.0% | 9.0% | $78.48 | +115% |
| Bull | 16.0% | 8.0% | $136.19 | +273% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $101.42 | $108.51 | $117.18 | $128.01 | $141.94 |
| 8.0% | $84.23 | $88.83 | $94.27 | $100.79 | $108.76 |
| 9.0% | $71.70 | $74.85 | $78.48 | $82.71 | $87.71 |
| 10.0% | $62.19 | $64.42 | $66.96 | $69.85 | $73.20 |
| 11.0% | $54.72 | $56.36 | $58.20 | $60.26 | $62.59 |
Where the presets come from
Base: years 1 to 5 grow at Pacira BioSciences, Inc.'s revenue growth rate over the last 5 fiscal years (11.1% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions